HomeFile

File

EMPIRE Trial: Is Microvascular Protection Feasible in PCI Depending on the Stenting Technique?

Percutaneous coronary intervention (PCI) may entail inherent complications, such as a diagnosis of periprocedural myocardial infarction (MI...

Stent Optimal Minimal Area and Stent Underexpansion Impact in 2-Stent Left Main Treatment

The upfront 2-stent strategy for left main bifurcation treatment presents a technical challenge and has been associated...

Severe Aortic Stenosis in Bicuspids: Promising Self-Expanding Valve Outcomes at 3 years

Bicuspid aortic valves represent a significant challenge in TAVR because of its anatomical complexity and the presence...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known...

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging,...

Myocardial Damage in MAC

Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in...

Initial Complete Revascularization vs. Staged Revascularization in Patients with STEMI and Multivessel Disease

In patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (primary PCI), multivessel...

Revascularization Timing in Acute Coronary Syndrome

Multivessel disease is often present in ST elevation acute myocardial infarction (STEMI) patients. The AHA/ACC 2021 revascularization...